vs
CareDx, Inc.（CDNA）与Ranger Energy Services, Inc.（RNGR）财务数据对比。点击上方公司名可切换其他公司
Ranger Energy Services, Inc.的季度营收约是CareDx, Inc.的1.2倍（$142.2M vs $117.7M），CareDx, Inc.净利率更高（2.4% vs 2.3%，领先0.1%），CareDx, Inc.同比增速更快（39.0% vs -0.6%），Ranger Energy Services, Inc.自由现金流更多（$17.1M vs $514.0K），过去两年CareDx, Inc.的营收复合增速更高（12.9% vs 1.9%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
Ranger Energy Services是北美领先的陆上油田服务提供商，为上游油气运营商提供完井、修井、钻机作业及产能优化等全套解决方案，业务主要覆盖美国本土的页岩和致密资源开采作业区。
CDNA vs RNGR — 直观对比
营收规模更大
RNGR
是对方的1.2倍
$117.7M
营收增速更快
CDNA
高出39.6%
-0.6%
净利率更高
CDNA
高出0.1%
2.3%
自由现金流更多
RNGR
多$16.6M
$514.0K
两年增速更快
CDNA
近两年复合增速
1.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $142.2M |
| 净利润 | $2.8M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | 1.0% | 2.3% |
| 净利率 | 2.4% | 2.3% |
| 营收同比 | 39.0% | -0.6% |
| 净利润同比 | — | -44.8% |
| 每股收益（稀释后） | $0.05 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNARNGR
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | $142.2M | ||
| Q3 25 | $100.1M | $128.9M | ||
| Q2 25 | $86.7M | $140.6M | ||
| Q1 25 | $84.7M | $135.2M | ||
| Q4 24 | $86.6M | $143.1M | ||
| Q3 24 | $82.9M | $153.0M | ||
| Q2 24 | $92.3M | $138.1M |
净利润CDNARNGR
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | $3.2M | ||
| Q3 25 | $1.7M | $1.2M | ||
| Q2 25 | $-8.6M | $7.3M | ||
| Q1 25 | $-10.4M | $600.0K | ||
| Q4 24 | $87.7M | $5.8M | ||
| Q3 24 | $-10.6M | $8.7M | ||
| Q2 24 | $-4.6M | $4.7M |
营业利润率CDNARNGR
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | 2.3% | ||
| Q3 25 | -0.2% | 2.0% | ||
| Q2 25 | -12.8% | 6.1% | ||
| Q1 25 | -15.8% | 0.7% | ||
| Q4 24 | 97.5% | 6.2% | ||
| Q3 24 | -16.6% | 8.4% | ||
| Q2 24 | -7.9% | 5.3% |
净利率CDNARNGR
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | 2.3% | ||
| Q3 25 | 1.7% | 0.9% | ||
| Q2 25 | -9.9% | 5.2% | ||
| Q1 25 | -12.2% | 0.4% | ||
| Q4 24 | 101.3% | 4.1% | ||
| Q3 24 | -12.8% | 5.7% | ||
| Q2 24 | -5.0% | 3.4% |
每股收益（稀释后）CDNARNGR
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | $0.14 | ||
| Q3 25 | $0.03 | $0.05 | ||
| Q2 25 | $-0.16 | $0.32 | ||
| Q1 25 | $-0.19 | $0.03 | ||
| Q4 24 | $1.60 | $0.24 | ||
| Q3 24 | $-0.20 | $0.39 | ||
| Q2 24 | $-0.09 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $300.1M |
| 总资产 | $411.1M | $419.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDNARNGR
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | $10.3M | ||
| Q3 25 | $194.2M | $45.2M | ||
| Q2 25 | $186.3M | $48.9M | ||
| Q1 25 | $230.9M | $40.3M | ||
| Q4 24 | $260.7M | $40.9M | ||
| Q3 24 | $240.9M | $14.8M | ||
| Q2 24 | $228.9M | $8.7M |
总债务CDNARNGR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | $0 | $0 | ||
| Q2 24 | $0 | $0 |
股东权益CDNARNGR
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | $300.1M | ||
| Q3 25 | $311.1M | $270.0M | ||
| Q2 25 | $327.4M | $276.9M | ||
| Q1 25 | $379.3M | $272.6M | ||
| Q4 24 | $378.4M | $273.8M | ||
| Q3 24 | $273.2M | $267.6M | ||
| Q2 24 | $264.7M | $260.5M |
总资产CDNARNGR
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | $419.3M | ||
| Q3 25 | $432.3M | $372.8M | ||
| Q2 25 | $444.3M | $381.7M | ||
| Q1 25 | $489.6M | $376.5M | ||
| Q4 24 | $491.1M | $381.6M | ||
| Q3 24 | $477.0M | $373.9M | ||
| Q2 24 | $466.8M | $359.6M |
负债/权益比CDNARNGR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 0.00× | 0.00× | ||
| Q2 24 | 0.00× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $24.1M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | $17.1M |
| 自由现金流率自由现金流/营收 | 0.4% | 12.0% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | 1.54× | 7.53× |
| 过去12个月自由现金流最近4个季度 | — | $42.9M |
8季度趋势，按日历期对齐
经营现金流CDNARNGR
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | $24.1M | ||
| Q3 25 | $37.4M | $13.6M | ||
| Q2 25 | $9.9M | $20.7M | ||
| Q1 25 | $-26.6M | $10.6M | ||
| Q4 24 | $21.9M | $32.7M | ||
| Q3 24 | $12.5M | $17.7M | ||
| Q2 24 | $18.9M | $22.1M |
自由现金流CDNARNGR
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | $17.1M | ||
| Q3 25 | — | $8.0M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | — | $27.3M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | — | $6.8M |
自由现金流率CDNARNGR
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 19.1% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 4.9% |
资本支出强度CDNARNGR
| Q1 26 | — | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 11.1% |
现金转化率CDNARNGR
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | 7.53× | ||
| Q3 25 | 22.30× | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | — | 17.67× | ||
| Q4 24 | 0.25× | 5.64× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 4.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
